Watch the latest in the series of transatlantic talking heads, a joint collaboration of the Crohn’s & Colitis Foundation and the European Crohn’s & Colitis Organization, on the role of biosimilars.
Perspectives on Biosimilars
Perspectives on Biosimilars
4
- Host: Millie D. Long, MD, MPH
- Guest: David T. Rubin, MD
- Guest: Silvio Danese, MD
What role do biosimilars play in the management of IBD?
Recommended
- 0
Medical Therapy
Management of Intestinal Strictures in Crohn’s disease
- 5
Medical Therapy
Addressing Extra-Intestinal Manifestations (EIMs) in IBD
Gastroenterology and Hepatology
Current and Future Developments of Predictive Markers and Prognostic Testing in…
Practice Resources & Guidelines
Overview of IBD for Early Career Healthcare Professionals
Facebook Comments